Clinical Trials
28 trialsECP
Centre Chirurgical Marie Lannelongue
LUNG-RESIST
University Hospital, Toulouse
KOBE
University Hospital, Toulouse
RICEPS-2
University Hospital, Tours
PneumoTAV001
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
The Institute of Molecular and Translational Medicine, Czech Republic
BREATHE
Nantes University Hospital
ULYSSE
Hospices Civils de Lyon
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
Hasselt University
BCBPoumon
Institut du Cancer de Montpellier - Val d'Aurelle
PROGRESS
UNC Lineberger Comprehensive Cancer Center
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
University of Arkansas
EXODIAG
Centre Georges Francois Leclerc
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
Lymphocyte Depletion and Change in Lymphocyte Functionality
University of Virginia
CANTO
UNICANCER
ARIA
Scientific Institute San Raffaele
BIOCEPTION
Assistance Publique Hopitaux De Marseille
PREVALUNG*
Assistance Publique Hopitaux De Marseille
HEPATICI
Centre Hospitalier Universitaire, Amiens
EMBRaCE-GM
Manchester University NHS Foundation Trust
ONCOPRO
Hospices Civils de Lyon
ECTOPIC/MUTAS
University Hospital, Grenoble
POIR
Centre Hospitalier Universitaire de Saint Etienne
ALCAPONE
Centre Georges Francois Leclerc
CIRCUBRONCH
Central Hospital, Nancy, France
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
University of Miami
Tumor Markers in Lung Cancer: DCAMLK-1LK-1
University of Oklahoma